Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription Articles published in Diabetes Retrieve available abstracts of 103 articles: HTML format

Single Articles

July 2026
1. LI S, Wang J, Xin C, Dong Y, et al
   beta-Hydroxybutyrate Improves Glucose Metabolism in Streptozotocin-Induced Type 1 Diabetes by Inhibiting Gut and Liver Glucose Transporters via GPR109A.
   Diabetes. 2026;75:1125-1141.
   PubMed     Abstract available
   
   
   May 2026
2. KOPRIVICA I, Jonic N, Dimitrijevic M, Jevtic B, et al
   Activation of Intestinal Type 3 Innate Lymphoid Cells and Regulatory T Cells Through Free Fatty Acid Receptor 2 Ameliorates Type 1 Diabetes in Mice.
   Diabetes. 2026 May 18:db250742. doi: 10.2337/db25-0742.
   PubMed     Abstract available
   
   
   
3. ONIZUKA S, Shinjo T, Ishikado A, Wu IH, et al
   Protection Against Periodontitis by Improving Mitochondrial Function in Diabetes.
   Diabetes. 2026 May 15:db250849. doi: 10.2337/db25-0849.
   PubMed     Abstract available
   
   
   
4. AMENDOLARA R, De Vita F, Abedi V, Luvera D, et al
   Distinct Interplay Between beta-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes.
   Diabetes. 2026 May 11:db250933. doi: 10.2337/db25-0933.
   PubMed     Abstract available
   
   
   
5. SORUM NE, Warnoe J, Holst JJ, Hartmann B, et al
   The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.
   Diabetes. 2026 May 5:db251128. doi: 10.2337/db25-1128.
   PubMed     Abstract available
   
   
   April 2026
6. DAO GM, Zhao S, Schofield C, Vogrin S, et al
   Whey Protein Ingestion Stimulates Glucagon Secretion and Raises Blood Glucose Levels in Adults With Type 1 Diabetes.
   Diabetes. 2026 Apr 24:db260059. doi: 10.2337/db26-0059.
   PubMed     Abstract available
   
   
   
7. PUGLIESE A
   Distinct Host Responses to Enterovirus in Children With Islet Autoimmunity Provide a New Framework for the Role of Infections in Type 1 Diabetes.
   Diabetes. 2026;75:603-605.
   PubMed    
   
   
   March 2026
8. YE J, Qiu Y, Aguilan JT, Sun Y, et al
   The Downregulation of Type 1 Diabetes Susceptibility Gene PGM1 Induces Metabolic Imbalance and Stress in Pancreatic beta-Cells.
   Diabetes. 2026 Mar 31:db250191. doi: 10.2337/db25-0191.
   PubMed     Abstract available
   
   
   
9. DWYER JR, Racine JJ, Chapman HD, Bell A, et al
   Multiple Mechanisms Contribute to Robust Type 1 Diabetes Protection in Nfkbid- Overexpressing NOD Mice.
   Diabetes. 2026 Mar 20:db250956. doi: 10.2337/db25-0956.
   PubMed    
   
   
   
10. MONTASER E, Sosenko JM, Ismail HM
    Predicting the Timing of the Metabolic Inflection Point in Type 1 Diabetes Progression Using Machine Learning and Survival Analysis Models.
    Diabetes. 2026 Mar 20:db250961. doi: 10.2337/db25-0961.
    PubMed     Abstract available
    
    
    
11. SAKAKI K, Murakami T, Yoshida H, Otani D, et al
    Quantitative beta-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.
    Diabetes. 2026 Mar 12:db251127. doi: 10.2337/db25-1127.
    PubMed     Abstract available
    
    
    February 2026
12. BONFIELD G, Russ-Silsby J, Ramchand S, Luckett AM, et al
    Biallelic Pathogenic Variants in IL2RA Cause Neonatal-Onset Monogenic Autoimmune Diabetes.
    Diabetes. 2026 Feb 27:db250885. doi: 10.2337/db25-0885.
    PubMed     Abstract available
    
    
    
13. RAINERI D, Savastio S, Bellone S, Scotti L, et al
    Memory Regulatory T Cells as a Biomarker of Early Type I Diabetes.
    Diabetes. 2026 Feb 23:db250161. doi: 10.2337/db25-0161.
    PubMed     Abstract available
    
    
    
14. DELGADO-CORRALES B, Fingerhut L, Leung P, Yau CSA, et al
    Distinct Enterovirus Antigen Landscape in Children With Islet Autoimmunity.
    Diabetes. 2026 Feb 9:db250805. doi: 10.2337/db25-0805.
    PubMed     Abstract available
    
    
    January 2026
15. GREENBAUM CJ, Long SA, Gitelman SE, Gaglia JL, et al
    Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.
    Diabetes. 2026 Jan 21:db250777. doi: 10.2337/db25-0777.
    PubMed     Abstract available
    
    
    
16. JIA X, Zhang C, Waugh K, Miao D, et al
    Identifying Insulin Autoantibodies With Differential Risk in Type 1 Diabetes With a Novel Bridging ELISA.
    Diabetes. 2026 Jan 12:db250696. doi: 10.2337/db25-0696.
    PubMed     Abstract available
    
    
    
17. OSHIMA M, Halliez C, Kobaisi F, Mode N, et al
    Killing of Human beta-Cells by CD8+ T Cells Triggers Inflammatory Paracrine Signaling and Neighboring beta-Cell Dysfunction.
    Diabetes. 2026;75:124-132.
    PubMed     Abstract available
    
    
    
18. GONCALVES LM, Shirvaikar I, Sideris K, Pereira E, et al
    Microvascular Homeostasis Is Compromised in Pancreatic Islets in a Mouse Model of beta-Cell Loss and Low-Grade Inflammation.
    Diabetes. 2026;75:70-84.
    PubMed     Abstract available
    
    
    December 2025
19. TRIOLO TM, Sosenko JM, Cuthbertson D, Oram RA, et al
    Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression.
    Diabetes. 2025 Dec 10:db250711. doi: 10.2337/db25-0711.
    PubMed     Abstract available
    
    
    
20. ZHAO LP, Papadopoulos GK, Skyler JS, Parikh HM, et al
    Profiling Associations Between IGHG-FCGR Ligand-Receptor Interactions and Disease Progression From Stage 1 and 2 to Stage 3 Type 1 Diabetes.
    Diabetes. 2025 Dec 3:db250610. doi: 10.2337/db25-0610.
    PubMed     Abstract available
    
    
    November 2025
21. WILSON CS, Stocks BT, Falk AC, Moore DJ, et al
    B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes.
    Diabetes. 2025 Nov 25:db250241. doi: 10.2337/db25-0241.
    PubMed     Abstract available
    
    
    
22. RUCHI FNU, Schiavon M, Pandey A, Dalla Man C, et al
    Postprandial Glucagon Metabolism in Healthy and Type 1 Diabetes.
    Diabetes. 2025 Nov 20:db250587. doi: 10.2337/db25-0587.
    PubMed     Abstract available
    
    
    
23. DEUTSCH AJ, Bell AS, Michalek DA, Burkholder AB, et al
    Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score.
    Diabetes. 2025 Nov 14:db250772. doi: 10.2337/db25-0772.
    PubMed     Abstract available
    
    
    
24. GALDERISI A, Carr ALJ, Taylor P, Bonet J, et al
    Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes.
    Diabetes. 2025 Nov 14:db250801. doi: 10.2337/db25-0801.
    PubMed     Abstract available
    
    
    
25. PITA-GRISANTI V, Martins Pecanha FL, Louzada RA, Blandino-Rosano M, et al
    Protection Against Type 1 Diabetes Development in Mice With 4E-BP2 Deletion.
    Diabetes. 2025 Nov 14:db250348. doi: 10.2337/db25-0348.
    PubMed     Abstract available
    
    
    
26. OROZCO S, Aljobaily N, Reynolds HM, Oceguera GA, et al
    Flt3L-Derived Antigen-Presenting Cell Transfer in Neonatal NOD Mice Reduces the Incidence of Type 1 Diabetes.
    Diabetes. 2025 Nov 6:db250055. doi: 10.2337/db25-0055.
    PubMed     Abstract available
    
    
    
27. BLOM SE, Narsian PR, Behan-Bush RM, Ankrum JA, et al
    Proinflammatory Cytokines Mediate Pancreatic beta-Cell-Specific Alterations to Golgi Integrity via iNOS-Dependent Mitochondrial Inhibition.
    Diabetes. 2025;74:1992-2007.
    PubMed     Abstract available
    
    
    October 2025
28. GROEGLER J, Mangold K, Nicholson K, Dang M, et al
    Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD Mice.
    Diabetes. 2025 Oct 21:db250324. doi: 10.2337/db25-0324.
    PubMed     Abstract available
    
    
    
29. HAMPE CS, Kamat V, Bryan CL, Pyle L, et al
    Deleterious Effects of a GAD65 Monoclonal Autoantibody on Islet Function.
    Diabetes. 2025 Oct 10:db250475. doi: 10.2337/db25-0475.
    PubMed     Abstract available
    
    
    September 2025
30. FLAMMER ER, Christopher MW, Powers ER, Broncucia H, et al
    Serum Metabolomics Reveals Potential Differences in Gut Microbiota-Associated Metabolites in Twins Discordant for Type 1 Diabetes.
    Diabetes. 2025 Sep 11:db250156. doi: 10.2337/db25-0156.
    PubMed     Abstract available
    
    
    
31. GILLESPIE KM
    Islet Autoantibody Testing as Type 1 Diabetes Early Detection Enters Mainstream Health Care.
    Diabetes. 2025;74:1466-1468.
    PubMed    
    
    
    August 2025
32. SIMS EK, Russell WE, Cuthbertson D, Skyler JS, et al
    Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval.
    Diabetes. 2025 Aug 28:db250310. doi: 10.2337/db25-0310.
    PubMed     Abstract available
    
    
    
33. REYNOLDS KM, Sun Q, Zhang Y, Umans J, et al
    Diabetes Genetic Clusters and Clinical Outcomes in American Indians.
    Diabetes. 2025 Aug 18:db250322. doi: 10.2337/db25-0322.
    PubMed     Abstract available
    
    
    
34. ZHOU X, Iakovliev A, McGurnaghan S, Erabadda B, et al
    Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes.
    Diabetes. 2025 Aug 11:db250067. doi: 10.2337/db25-0067.
    PubMed     Abstract available
    
    
    July 2025
35. EVANS-MOLINA C, Dor Y, Lernmark A, Mathieu C, et al
    The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum.
    Diabetes. 2025 Jul 30:dbi250011. doi: 10.2337/dbi25-0011.
    PubMed     Abstract available
    
    
    
36. DROTAR DM, Vazquez Ramos GJA, Williams MD, David ST, et al
    Loss of Insulin-Positive Cell Clusters Precedes the Decrease in Islet Frequency and beta-Cell Area in Type 1 Diabetes.
    Diabetes. 2025 Jul 24:db250326. doi: 10.2337/db25-0326.
    PubMed     Abstract available
    
    
    
37. MARINAC M, Rickels MR, Gaglia JL, O'Connell PJ, et al
    Future Directions and Clinical Trial Considerations for Novel Islet beta-Cell Replacement Therapies for Type 1 Diabetes.
    Diabetes. 2025 Jul 15:dbi240037. doi: 10.2337/dbi24-0037.
    PubMed     Abstract available
    
    
    
38. WASSERFALL CH, Forsmark CE, Li S, Li L, et al
    Type 1 Diabetes Autoantibodies in Acute, Recurrent Acute, and Chronic Pancreatitis.
    Diabetes. 2025 Jul 9:db240931. doi: 10.2337/db24-0931.
    PubMed     Abstract available
    
    
    June 2025
39. SHEANON N, Warner SO, Dai Y, Whitsett NH, et al
    Fasting Lowers Glucagon Levels Under Basal Conditions and During Insulin-Induced Hypoglycemia in Individuals With Type 1 Diabetes.
    Diabetes. 2025 Jun 30:db250251. doi: 10.2337/db25-0251.
    PubMed     Abstract available
    
    
    
40. GIANFRANI C, Camarca A, Picascia S, Vitale S, et al
    T-Cell Mediated Immunity to Gliadin Is Elicited in the Gut Mucosa of Type 1 Diabetes Patients Only in Presence of Celiac Disease Comorbidity.
    Diabetes. 2025 Jun 24:db241120. doi: 10.2337/db24-1120.
    PubMed     Abstract available
    
    
    
41. BERG-HANSEN K, Bangshaab M, Gopalasingam N, Nielsen R, et al
    The Cardiac and Hemodynamic Effects of Ketone Bodies Are Abnormal in Patients With Type 1 Diabetes: A Randomized Controlled Trial.
    Diabetes. 2025 Jun 17:db250243. doi: 10.2337/db25-0243.
    PubMed     Abstract available
    
    
    
42. PIPELLA J, Motlagh RA, Rampazzo Morelli N, Thompson PJ, et al
    Autoreactive T Cells and Cytokine Stress Drive beta-Cell Senescence Entry and Accumulation in Type 1 Diabetes.
    Diabetes. 2025 Jun 11:db241122. doi: 10.2337/db24-1122.
    PubMed     Abstract available
    
    
    
43. MAURAS N, Ma Q, Weinzimer SA, White NH, et al
    Differences in White Matter Microstructure in Children With Type 1 Diabetes Persist During Longitudinal Follow-up: Relation to Dysglycemia.
    Diabetes. 2025 Jun 2:db240684. doi: 10.2337/db24-0684.
    PubMed     Abstract available
    
    
    
44. AKHBARI P, Perez-Hernandez J, Russell MA, Dhayal S, et al
    Soluble HLA Class I Is Released From Human beta-Cells Following Exposure to Interferons.
    Diabetes. 2025;74:956-968.
    PubMed     Abstract available
    
    
    
45. WATSON TK, Rosen ABI, Drow T, Medjo JA, et al
    Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell-Intrinsic Immune Tolerance.
    Diabetes. 2025;74:943-955.
    PubMed     Abstract available
    
    
    
46. THOMSON EA, Lee S, Xu H, Moeller H, et al
    Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics.
    Diabetes. 2025;74:873-884.
    PubMed     Abstract available
    
    
    
47. BRUCE CR, Ang T, Toms JD, Dao GM, et al
    The Effect of Small Increases in Blood Glucose on Insulin Secretion and Endogenous Glucose Production in Humans.
    Diabetes. 2025;74:898-906.
    PubMed     Abstract available
    
    
    May 2025
48. RUCHI FNU, Schiavon M, Yadav Y, Dalla Man C, et al
    Splanchnic and Leg Glucagon Metabolism in Healthy and Type 1 Diabetes: First in Human Study Using [13C9, 15N1]-Glucagon.
    Diabetes. 2025 May 30:db241064. doi: 10.2337/db24-1064.
    PubMed     Abstract available
    
    
    
49. FAN KS, Shojaee-Moradie F, Jeivad F, Manoli A, et al
    A Dual Stable Isotope Study of the Effect of Altitude and Simulated Flight on Glucose Metabolism in Type 1 Diabetes: A Randomized Crossover Study.
    Diabetes. 2025 May 28:db250004. doi: 10.2337/db25-0004.
    PubMed     Abstract available
    
    
    
50. WILLIAMS JM, Hilmes MA, Letourneau-Freiberg LR, Kandasamy B, et al
    Smaller Pancreas Volume in Insulin-Dependent Monogenic Diabetes.
    Diabetes. 2025 May 22:db250318. doi: 10.2337/db25-0318.
    PubMed     Abstract available
    
    
    
51. FLATT AJ, Matus AM, Gallop RJ, Markmann E, et al
    beta-Cell Secretory Capacity Predicts Metabolic Outcomes Over 6 Years After Human Islet Transplantation.
    Diabetes. 2025;74:749-759.
    PubMed     Abstract available
    
    
    April 2025
52. HERING BJ, Rickels MR, Bellin MD, Millman JR, et al
    Advances in Cell Replacement Therapies for Diabetes.
    Diabetes. 2025 Apr 24:db250037. doi: 10.2337/db25-0037.
    PubMed     Abstract available
    
    
    
53. PARENT AV, Agarwal A, Alvarez-Dominguez JR, Arrojo E Drigo R, et al
    Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human Islet Research Network (HIRN) Initiative.
    Diabetes. 2025 Apr 24:db250097. doi: 10.2337/db25-0097.
    PubMed     Abstract available
    
    
    
54. JONES TLZ, Kusmartseva I, Litovsky S, Thakar R, et al
    The Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D): An NIDDK Initiative to Advance Understanding of Mechanisms Underlying Cardiovascular Disease in Type 1 Versus Type 2 Diabetes.
    Diabetes. 2025 Apr 24:db250017. doi: 10.2337/db25-0017.
    PubMed     Abstract available
    
    
    
55. ISMAIL HM, Cuthbertson D, Galderisi A, Libman I, et al
    The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes.
    Diabetes. 2025 Apr 2:db241000. doi: 10.2337/db24-1000.
    PubMed     Abstract available
    
    
    
56. BILAL A, Casu A, Yi F, Dutta T, et al
    A Randomized-Controlled, Double-Masked Cross-Over Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
    Diabetes. 2025 Apr 2:db250096. doi: 10.2337/db25-0096.
    PubMed     Abstract available
    
    
    March 2025
57. KRISCHER JP, Muller S, You L, Achenbach P, et al
    A Comparative Analysis of the Sensitivity, Specificity, Concordance, and the 5-year Predictive Power of Diabetes-related Autoantibody Assays.
    Diabetes. 2025 Mar 10:db240814. doi: 10.2337/db24-0814.
    PubMed     Abstract available
    
    
    February 2025
58. LEE J, Ustione A, Wilkerson EM, Balakrishnan R, et al
    Regulation of Type 1 Diabetes via Brown Adipocyte-Secreted Proteins and the Novel Glucagon Regulator Nidogen-2.
    Diabetes. 2025 Feb 28:db241003. doi: 10.2337/db24-1003.
    PubMed     Abstract available
    
    
    January 2025
59. JIA X, Wenzlau JM, Zhang C, Dong F, et al
    Strong Association of Autoantibodies Targeting Deamidated Extracellular Epitopes of Insulinoma Antigen-2 (IA-2) with Clinical Onset of Type 1 Diabetes.
    Diabetes. 2025 Jan 16:db240571. doi: 10.2337/db24-0571.
    PubMed     Abstract available
    
    
    
60. HOHENSTEIN AC, Gallegos J, Dang M, Groegler J, et al
    Novel T Cell reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Subjects.
    Diabetes. 2025 Jan 16:db240611. doi: 10.2337/db24-0611.
    PubMed     Abstract available
    
    
    
61. LU T, Manousaki D, Sun L, Paterson AD, et al
    Integrative proteogenomic analyses provide novel interpretations of type 1 diabetes risk loci through circulating proteins.
    Diabetes. 2025 Jan 6:db240380. doi: 10.2337/db24-0380.
    PubMed     Abstract available
    
    
    
62. YANG WX, Su K, Liao MC, Zhou J, et al
    Renal Tubule-Specific Angiotensinogen Deletion Attenuates SGLT2 Expression and Ameliorates Diabetic Kidney Disease in Murine Models of Type 1 Diabetes.
    Diabetes. 2025 Jan 3:db240553. doi: 10.2337/db24-0553.
    PubMed     Abstract available
    
    
    November 2024
63. NG STH, Price MJ, Richardson N, Nawaf M, et al
    Pre-clinical development of a tolerogenic peptide from glutamate decarboxylase as a candidate for antigen-specific immunotherapy in type 1 diabetes.
    Diabetes. 2024 Nov 21:db230996. doi: 10.2337/db23-0996.
    PubMed     Abstract available
    
    
    
64. ROSHANDEL D, Spiliopoulou A, McGurnaghan SJ, Iakovliev A, et al
    Genetics of C-peptide and Age at Diagnosis in Type 1 Diabetes.
    Diabetes. 2024 Nov 18:db240340. doi: 10.2337/db24-0340.
    PubMed     Abstract available
    
    
    
65. MCNITT DH, Williams JM, Santitoro JG, Kim J, et al
    Type 1 diabetes depends on CD4-driven expression of the transcriptional repressor, Bcl6.
    Diabetes. 2024 Nov 18:db230709. doi: 10.2337/db23-0709.
    PubMed     Abstract available
    
    
    
66. LUCKETT AM, Hawkes G, Green HD, De Franco E, et al
    Type 1 diabetes genetic risk contributes to phenotypic presentation in monogenic autoimmune diabetes.
    Diabetes. 2024 Nov 12:db240485. doi: 10.2337/db24-0485.
    PubMed     Abstract available
    
    
    October 2024
67. MALLONE R, Sims E, Achenbach P, Mathieu C, et al
    Emerging concepts and success stories in type 1 diabetes research: a roadmap for a bright future.
    Diabetes. 2024 Oct 24:db240439. doi: 10.2337/db24-0439.
    PubMed     Abstract available
    
    
    
68. BARRA JM, Kratz AT, Castro-Gutierrez R, Proia J, et al
    Cryopreservation of Stem Cell-Derived beta-Like Cells Enriches for Insulin-Producing Cells With Improved Function.
    Diabetes. 2024;73:1687-1696.
    PubMed     Abstract available
    
    
    September 2024
69. ALMUTAIRI A, White TD, Stephenson DJ, Stephenson BD, et al
    Selective Reduction of Ca2+-Independent Phospholipase A2beta (iPLA2beta)-Derived Lipid Signaling from Macrophages Mitigates Type 1 Diabetes Development.
    Diabetes. 2024 Sep 16:db230770. doi: 10.2337/db23-0770.
    PubMed     Abstract available
    
    
    
70. LIU Y, Wang S, Wang Z, Yu J, et al
    Recent Progress in Glucose-Responsive Insulin.
    Diabetes. 2024;73:1377-1388.
    PubMed     Abstract available
    
    
    August 2024
71. GREENBAUM CJ, Nepom GT, Wood-Heickman LK, Wherrett DK, et al
    Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1 Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee Workshop.
    Diabetes. 2024 Aug 21:dbi240020. doi: 10.2337/dbi24-0020.
    PubMed     Abstract available
    
    
    
72. SHEN Y, Shi R, Lu S, Wang Y, et al
    Role of Peptidyl arginine deiminase 4-dependent macrophage extracellular traps formation on Type 1 Diabetes pathogenesis.
    Diabetes. 2024 Aug 13:db231000. doi: 10.2337/db23-1000.
    PubMed     Abstract available
    
    
    
73. MARTINO M, Galderisi A, Evans-Molina C, Dayan C, et al
    Revisiting the pattern of loss of beta-cell function in preclinical Type 1 Diabetes.
    Diabetes. 2024 Aug 6:db240163. doi: 10.2337/db24-0163.
    PubMed     Abstract available
    
    
    July 2024
74. MANDUCHI E, Descamps HC, Schug J, Da T, et al
    No evidence for persistent enteroviral B infection of pancreatic islets in type 1 diabetic and pre-diabetic patients from RNA-Seq data.
    Diabetes. 2024 Jul 31:db240076. doi: 10.2337/db24-0076.
    PubMed     Abstract available
    
    
    
75. GRACE SL, Gillespie KM, Williams CL, Lampasona V, et al
    Autoantibodies to truncated GAD(96-585) antigen stratify risk of early insulin requirement in adult-onset diabetes.
    Diabetes. 2024 Jul 8:db230980. doi: 10.2337/db23-0980.
    PubMed     Abstract available
    
    
    
76. SUNILKUMAR S, Dennis MD
    REDD1 is a Promising Therapeutic Target to Combat the Development of Diabetic Complications: A Report on Research Supported by Pathway to Stop Diabetes.
    Diabetes. 2024 Jul 8:dbi240013. doi: 10.2337/dbi24-0013.
    PubMed     Abstract available
    
    
    
77. KJELDSEN SAS, Richter MM, Jensen NJ, Nilsson MSD, et al
    Glucagon resistance in individuals with obesity and hepatic steatosis can be measured using the GLUSENTIC test and index.
    Diabetes. 2024 Jul 8:db230858. doi: 10.2337/db23-0858.
    PubMed     Abstract available
    
    
    
78. SCHRODERUS AM, Pitkanen V, Ekman I, Stevens D, et al
    Temporal Alterations in CD8+ T Cells During the Progression from Stage 1 to Stage 3 Type 1 Diabetes.
    Diabetes. 2024 Jul 5:db240159. doi: 10.2337/db24-0159.
    PubMed     Abstract available
    
    
    June 2024
79. LESLIE KA, Lekka C, Richardson SJ, Russell MA, et al
    Regulation of STAT1 signalling in human pancreatic beta-cells by the lysine deacetylase, HDAC6; a new therapeutic opportunity in type 1 diabetes?
    Diabetes. 2024 Jun 13:db240008. doi: 10.2337/db24-0008.
    PubMed     Abstract available
    
    
    May 2024
80. YANG Z, Zhang Z, Li L, Jing Z, et al
    Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-onset Type 1 Diabetes.
    Diabetes. 2024 May 21:db230987. doi: 10.2337/db23-0987.
    PubMed     Abstract available
    
    
    
81. FRORUP C, Jensen MH, Haupt-Jorgensen M, Buschard K, et al
    Elevated cathepsin S serum levels in new-onset type 1 diabetes and autoantibody-positive siblings.
    Diabetes. 2024 May 3:db230911. doi: 10.2337/db23-0911.
    PubMed     Abstract available
    
    
    April 2024
82. EVANS-MOLINA C
    The Ailing beta-Cell in Diabetes: Insights From a Trip to the ER: The 2023 Outstanding Scientific Achievement Award Lecture.
    Diabetes. 2024;73:545-553.
    PubMed     Abstract available
    
    
    
83. DRAWSHY Z, Neiman D, Fridlich O, Peretz A, et al
    DNA Methylation-Based Assessment of Cell Composition in Human Pancreas and Islets.
    Diabetes. 2024;73:554-564.
    PubMed     Abstract available
    
    
    March 2024
84. KIM YK, Kim YR, Wells KL, Sarbaugh D, et al
    PTPN2 Regulates Metabolic Flux to Affect beta-Cell Susceptibility to Inflammatory Stress.
    Diabetes. 2024;73:434-447.
    PubMed     Abstract available
    
    
    February 2024
85. KASINATHAN D, Guo Z, Sarver DC, Wong GW, et al
    Cell-surface ZnT8 antibody prevents and reverses autoimmune diabetes in mice.
    Diabetes. 2024 Feb 22:db230568. doi: 10.2337/db23-0568.
    PubMed     Abstract available
    
    
    
86. CALLEBAUT A, Guyer P, Derua R, Buitinga M, et al
    CD4+ T cells from individuals with type 1 diabetes respond to a novel class of deamidated peptides formed in pancreatic islets.
    Diabetes. 2024 Feb 22:db230588. doi: 10.2337/db23-0588.
    PubMed     Abstract available
    
    
    
87. LATRES E, Greenbaum CJ, Oyaski ML, Dayan CM, et al
    Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.
    Diabetes. 2024 Feb 13:dbi230012. doi: 10.2337/dbi23-0012.
    PubMed     Abstract available
    
    
    January 2024
88. CALLEBAUT A, Guyer P, Baker RL, Gallegos JB, et al
    An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes.
    Diabetes. 2024 Jan 31:db230622. doi: 10.2337/db23-0622.
    PubMed     Abstract available
    
    
    
89. CIOU JJ, Chien MW, Hsu CY, Liu YW, et al
    Excess Salt Intake Activates IL-21-dominant Autoimmune Diabetogenesis via A Saltregulated Ste20-related Proline/alanine-rich Kinase in CD4 T Cells.
    Diabetes. 2024 Jan 19:db230599. doi: 10.2337/db23-0599.
    PubMed     Abstract available
    
    
    
90. WYATT RC, Grace SL, Brigatti C, Marzinotto I, et al
    Improved specificity of glutamate decarboxylase 65 autoantibody measurement using luciferase-based immunoprecipitation system (LIPS) assays.
    Diabetes. 2024 Jan 17:db230550. doi: 10.2337/db23-0550.
    PubMed     Abstract available
    
    
    November 2023
91. KUGATHASAN L, Sridhar VS, Lovblom LE, Matta S, et al
    Interactive effects of Empagliflozin and Hyperglycemia on Urinary Amino Acids in Individuals with Type 1 Diabetes.
    Diabetes. 2023 Nov 28:db230694. doi: 10.2337/db23-0694.
    PubMed     Abstract available
    
    
    
92. LAI SWT, Hernandez-Castillo C, De Jesus Lopez Gonzalez E, Zoukari T, et al
    Methylglyoxal adducts are prognostic biomarkers for diabetic kidney disease in patients with type 1 diabetes.
    Diabetes. 2023 Nov 15:db230277. doi: 10.2337/db23-0277.
    PubMed     Abstract available
    
    
    
93. ILONEN J, Kiviniemi M, El-Amir MI, Nygard L, et al
    Increased Frequency of the HLA-DRB1*04:04-DQA1*03-DQB1*03:02 Haplotype among HLA-DQB1*06:02 Positive Children with Type 1 Diabetes.
    Diabetes. 2023 Nov 7:db230387. doi: 10.2337/db23-0387.
    PubMed     Abstract available
    
    
    
94. ELGAMAL RM, Kudtarkar P, Melton RL, Mummey HM, et al
    An Integrated Map of Cell Type-Specific Gene Expression in Pancreatic Islets.
    Diabetes. 2023;72:1719-1728.
    PubMed     Abstract available
    
    
    
95. THIRAWATANANOND P, Brown ME, Sachs LK, Arnoletti JM, et al
    Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability.
    Diabetes. 2023;72:1629-1640.
    PubMed     Abstract available
    
    
    October 2023
96. WRIGHT JJ, Eskaros A, Windon A, Bottino R, et al
    Exocrine pancreas in type 1 and type 2 diabetes: different patterns of fibrosis, metaplasia, angiopathy, and adiposity.
    Diabetes. 2023 Oct 26:db230009. doi: 10.2337/db23-0009.
    PubMed     Abstract available
    
    
    
97. ZOU W, Chezhian J, Yu T, Liu W, et al
    Dissecting the roles of the nuclear and mitochondrial genomes in a mouse model of autoimmune diabetes.
    Diabetes. 2023 Oct 17:db230430. doi: 10.2337/db23-0430.
    PubMed     Abstract available
    
    
    
98. XU G, Chen J, Lu B, Sethupathy P, et al
    Verapamil Prevents Decline of IGF-I in Subjects With Type 1 Diabetes and Promotes beta-Cell IGF-I Signaling.
    Diabetes. 2023;72:1460-1469.
    PubMed     Abstract available
    
    
    September 2023
99. OBERHAUSER SS, l'Allemand D, Willems EP, Gozzi T, et al
    The slowing of peripheral nerve conduction velocity in children and adolescents with type 1 diabetes is predicted by glucose fluctuations.
    Diabetes. 2023 Sep 12:db230063. doi: 10.2337/db23-0063.
    PubMed     Abstract available
    
    
    July 2023
100. SASSI G, Licata G, Ventriglia G, Wouters A, et al
     A plasma miR-193b-365 signature combined with age and glycemic status predicts response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes.
     Diabetes. 2023 Jul 26:db220852. doi: 10.2337/db22-0852.
     PubMed     Abstract available
     
     
     
101. WRETLIND A, Curovic VR, Suvitaival T, Theilade S, et al
     Ceramides as risk markers for future cardiovascular events and all-cause mortality in long-standing type 1 diabetes.
     Diabetes. 2023 Jul 21:db230052. doi: 10.2337/db23-0052.
     PubMed     Abstract available
     
     
     
102. SCHON M, Zaharia OP, Strassburger K, Kupriyanova Y, et al
     Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes Mellitus.
     Diabetes. 2023 Jul 21:db230353. doi: 10.2337/db23-0353.
     PubMed     Abstract available
     
     
     
103. TANG Y, Ang L, Jaiswal M, Dillon BR, et al
     Cardiovascular autonomic neuropathy and risk of kidney function decline in type 1 and type 2 diabetes: findings from the PERL and ACCORD cohorts.
     Diabetes. 2023 Jul 19:db230247. doi: 10.2337/db23-0247.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum